Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation
Ekanayaka, P; Lee, SY; Herath, TUB; Kim, JH; Kim, TH; Lee, H; Chathuranga, K; Chathuranga, WAG; Park, JH; Lee, JS
Lee, JS (corresponding author), Chungnam Natl Univ, Coll Vet Med, Daejeon, South Korea.; Park, JH (corresponding author), Anim & Plant Quarantine Agcy, Gyeongsangbuk Do, South Korea.; Park, JH; Lee, JS (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.
PLOS PATHOGENS, 2020; 16 (11):